Important note: Information in this article was accurate in 2001. The state of the art may have changed since the publication date.
PRNewswire - November 16, 2001
A study entitled "Syndrome of Lipodystrophy, Hyperlipidemia, Insulin Resistance, and Diabetes in Treated Patient with Human Immunodeficiency Virus Infection" published in the November/December 2001 issue of Endocrine Practice summarizes six cases referred to the Vanderbilt Center for Diabetes Care. Endocrine Practice is the medical journal of the American Association of Clinical Endocrinologists (AACE).
Recent developments of different types of drugs have dramatically prolonged the lives of patients with AIDS. However, this prolongation of life and long-term use of antiviral agents have also produced a score of complications which influence the patients' quality of life and increased their risk of cardiovascular-related death. Examples of common AIDS-related endocrine disorders include insulin resistance and lipodystrophy syndrome.
"The cases presented in this report were among the first to be referred from the infectious disease clinic to a diabetes care center. There may be a large HIV-infected population with insulin resistance and lipodystrophy that is underserved," stated the studies author, Alan L. Graber, MD, FACE.
AACE is a professional medical organization dedicated to the optimal care of patients with endocrine problems such as diabetes, hyperandrogenic disorders, thyroid disorders, growth hormone deficiency, osteoporosis, cholesterol disorders, hypertension and obesity. Its 3,800 physician members are specialists with advanced training supported by AACE's state-of-the-art continuing education programs.
For further information on diabetes and other endocrine disorders or AACE guidelines visit the AACE Media Resource Room site at http://www.aace.com/pub/press .
011116
PR011128
Copyright © 2001 - PRNewswire. All rights reserved. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through PRNewswire, Permissions, 810 Seventh Ave., 32nd Floor, New York, NY 10019 http://www.PRNewswire.com.
AEGiS is made possible through unrestricted grants from Boehringer Ingelheim, iMetrikus, Inc., the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2001. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2001. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .